Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Silo Pharma Inc
(OP:
SILO
)
N/A
UNCHANGED
Last Price
Updated: 3:23 PM EDT, Sep 14, 2022
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Silo Pharma Inc
< Previous
1
2
3
4
Next >
Illinois Advocates Prepare to Introduce First Psychedelics Measure
May 20, 2022
Via
Investor Brand Network
PsychedelicNewsBreaks – Silo Pharma Inc. (SILO) Announces Milestone in Psilocybin Study on Parkinson’s Patients
May 19, 2022
Via
Investor Brand Network
FDA Expands Access to MDMA for Treatment of PTSD
May 18, 2022
Via
Investor Brand Network
Exposures
Product Safety
PsychedelicNewsBreaks – Silo Pharma Inc. (SILO) CEO Featured in Bell2Bell Podcast Episode
May 18, 2022
Via
Investor Brand Network
First Psychedelic Trial Clinic Set to Launch in London
May 17, 2022
Via
Investor Brand Network
Silo Pharma Inc. (SILO) Spotlight: Ketamine
May 12, 2022
Via
Investor Brand Network
Silo Pharma Inc. (SILO) Spotlight: Ketamine
May 11, 2022
Via
Investor Brand Network
Researchers Have Found Brain Cells That Die Due to Parkinson’s Disease
May 13, 2022
Via
Investor Brand Network
Study Finds Service Dogs Help Individuals with PTSD
May 10, 2022
Via
Investor Brand Network
3 Psychedelic Documentaries You Can Watch on YouTube
May 09, 2022
Via
Investor Brand Network
PsychedelicNewsBreaks – Silo Pharma Inc. (SILO), Frontage Laboratories to Collaborate in Pharmacokinetic Study
May 06, 2022
Via
Investor Brand Network
New Study Sheds Light on Inflammation Linked to COVID-19
May 05, 2022
Via
Investor Brand Network
Exposures
COVID-19
Studies Find Link Between ADHD, Fibromyalgia
May 04, 2022
Via
Investor Brand Network
Research Highlights the High Economic Cost of PTSD
April 29, 2022
Via
Investor Brand Network
Advocates Urge Use of Alternative Treatments to Curb Veteran Suicides
April 28, 2022
Via
Investor Brand Network
PsychedelicNewsBreaks – Silo Pharma Inc. (SILO) Focusing on Largely Underserved Indications
April 27, 2022
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
Study Evalutes Possible Link Between Parkinson’s Disease, Autoimmune Malfunction
April 27, 2022
Via
Investor Brand Network
Study Finds That Psychedelics Free Up Brains of Individuals with Depression
April 26, 2022
Via
Investor Brand Network
Silo Pharma Inc. (SILO) Advances with Pharmacokinetic Study – but What is Pharmacokinetics?
April 26, 2022
Via
Investor Brand Network
Scientists Stop Memory Decay by Administering Nasal Therapy to Mice
April 22, 2022
Via
Investor Brand Network
BioMedNewsBreaks – Silo Pharma Inc. (SILO) Produces First Batch of SPU-21 Liposomes for RA Study
April 20, 2022
Via
Investor Brand Network
Silo Pharma Inc. (SILO) Emerging Leader as Psychedelics ‘on the Cusp of Entering Mainstream Psychiatry’
April 11, 2022
Via
Investor Brand Network
BioMedNewsBreaks – Why Silo Pharma Inc. (SILO) Is ‘One to Watch’
April 07, 2022
Via
Investor Brand Network
BioMedNewsBreaks – Silo Pharma Inc. (SILO) Enters Agreement to Significantly Advance Technologies ‘Closer to the Clinic’
March 31, 2022
Via
Investor Brand Network
BioMedNewsBreaks – Silo Pharma Inc. (SILO) Initiates Coverage with InvestorBrandNetwork
March 30, 2022
Via
Investor Brand Network
Silo Pharma Inc. (SILO) Is ‘One to Watch’
March 30, 2022
Via
Investor Brand Network
4 Penny Stocks Insiders Are Buying
December 16, 2021
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders intereste...
Via
Benzinga
Silo Pharma Enters into Sponsored Research Agreement with Columbia University to Develop Psychedelic Therapeutics for Alzheimer's Disease
October 27, 2021
Agreement Provides for Option to License Alzheimer’s Therapeutic Englewood Cliffs, NJ, October 27, 2021 -- Silo Pharma, Inc. (OTCQB: SILO), a development-stage...
Via
Benzinga
Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation
October 18, 2021
The Week In Psychedelics
Via
Benzinga
There Are Now 50 Psychedelics Companies Listed In The U.S. - Here They Are
October 13, 2021
Just two years ago, the psychedelics sector was a small research space reserved for academics and extremely forward-thinking investors. S...
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.